In addition to IL6, CCL5 mRNA expression is highest in basal breast cancer, which is consistent with our experimental study showing that IL6 protein expressed by basal cancer cells conditions LEC to overexpress CCL5 protein4. The gene discussed is IL6; the disease is breast carcinoma.